Deal covers development of new products for cultivating and handling stem cells.
Vitrolife agreed to collaborate with Cellartis regarding the development of new products for cultivation, handling, and differentiation of stem cells. The two-year deal extends the present collaboration between the companies.
Cellartis focuses on research, development, and production of human embryonic stem cells and differential cells derived for stem cells. Vitrolife is a global biotechnology/medical device group that works with developing, manufacturing, and selling advanced products and systems for the preparation, cultivation and storage of human cells, tissue, and organs.